Literature DB >> 15917238

CD47 augments Fas/CD95-mediated apoptosis.

Partha P Manna1, Julie Dimitry, Per-Arne Oldenborg, William A Frazier.   

Abstract

Fas (CD95) mediates apoptosis of many cell types, but the susceptibility of cells to killing by Fas ligand and anti-Fas antibodies is highly variable. Jurkat T cells lacking CD47 (integrin-associated protein) are relatively resistant to Fas-mediated death but are efficiently killed by Fas ligand or anti-Fas IgM (CH11) upon expression of CD47. Lack of CD47 impairs events downstream of Fas activation including caspase activation, poly-(ADP-ribose) polymerase cleavage, cytochrome c release from mitochondria, loss of mitochondrial membrane potential, and DNA cleavage. Neither CD47 signaling nor raft association of CD47 is required to enable Fas apoptosis. CH11 induces association of Fas and CD47. Primary T cells from CD47-null mice are also protected from Fas-mediated killing relative to wild type T cells. Thus CD47 associates with Fas upon its activation and augments Fas-mediated apoptosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15917238     DOI: 10.1074/jbc.M500922200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  The matricellular protein thrombospondin-1 globally regulates cardiovascular function and responses to stress via CD47.

Authors:  David D Roberts; Thomas W Miller; Natasha M Rogers; Mingyi Yao; Jeffrey S Isenberg
Journal:  Matrix Biol       Date:  2012-01-14       Impact factor: 11.583

Review 2.  CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest.

Authors:  E Sick; A Jeanne; C Schneider; S Dedieu; K Takeda; L Martiny
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

Review 3.  CD47: a new target in cardiovascular therapy.

Authors:  Jeff S Isenberg; David D Roberts; William A Frazier
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-10       Impact factor: 8.311

Review 4.  Activated CD47 regulates multiple vascular and stress responses: implications for acute kidney injury and its management.

Authors:  Natasha M Rogers; Mingyi Yao; Enrico M Novelli; Angus W Thomson; David D Roberts; Jeffrey S Isenberg
Journal:  Am J Physiol Renal Physiol       Date:  2012-08-08

5.  Role of CD47 and Signal Regulatory Protein Alpha (SIRPα) in Regulating the Clearance of Viable or Aged Blood Cells.

Authors:  Oldenborg Per-Arne
Journal:  Transfus Med Hemother       Date:  2012-09-17       Impact factor: 3.747

6.  Therapeutic Targeting of CD47 to Modulate Tissue Responses to Ischemia and Radiation.

Authors:  David R Soto-Pantoja; Jeff S Isenberg; David D Roberts
Journal:  J Genet Syndr Gene Ther       Date:  2011-09-26

Review 7.  Programmed cell removal: a new obstacle in the road to developing cancer.

Authors:  Mark P Chao; Ravindra Majeti; Irving L Weissman
Journal:  Nat Rev Cancer       Date:  2011-12-08       Impact factor: 60.716

Review 8.  The Neuro-Immune-Regulators (NIREGs) Promote Tissue Resilience; a Vital Component of the Host's Defense Strategy against Neuroinflammation.

Authors:  Yosra Bedoui; Jim W Neal; Philippe Gasque
Journal:  J Neuroimmune Pharmacol       Date:  2018-06-16       Impact factor: 4.147

9.  Thrombospondin-1 and CD47 limit cell and tissue survival of radiation injury.

Authors:  Jeff S Isenberg; Justin B Maxhimer; Fuminori Hyodo; Michael L Pendrak; Lisa A Ridnour; William G DeGraff; Maria Tsokos; David A Wink; David D Roberts
Journal:  Am J Pathol       Date:  2008-09-11       Impact factor: 4.307

10.  Trauma patients' elevated tumor necrosis related apoptosis inducing ligand (TRAIL) contributes to increased T cell apoptosis.

Authors:  Gautam Bandyopadhyay; Paul E Bankey; Carol L Miller-Graziano
Journal:  Clin Immunol       Date:  2012-08-03       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.